Literature DB >> 6337176

Urinary growth hormone in man: evidence for multiple molecular forms.

G Baumann, E C Abramson.   

Abstract

Human GH (hGH) consists of several molecular forms. Monomeric forms present in pituitary extracts include the single chain, 22,000 mol wt form (22K; hGH-B); a 20,000 mol wt, single chain variant (20K); three proteolytically cleaved, two-chain forms (hGH-C, -D, and -E), acetylated, deaminated, and slow-migrating forms. It is not known which of these forms are secreted in vivo or whether peripheral organs contribute to the interconversion between some of these hGH forms. To answer these questions, we studied the molecular forms of hGH excreted in urine from normal volunteers and from an acromegalic patient, as urinary hGH presumably reflects integrated plasma hGH. hGH was extracted from urine by hollow fiber diafiltration and concentration, followed by immunoadsorbent chromatography. The extracted hGH was examined by polyacrylamide gel electrophoresis under native as well as denaturing and reducing conditions and by isoelectric focusing. The predominant form of hGH in both normal urine and urine from the acromegalic patient was 22K, with small quantities (approximately 10%) of 20K and an unidentified acidic form also present. Cleaved forms with enhanced bioactivity (hGH-D and -E) and big hGH forms were not detectable. We conclude that 1) the pattern of urinary hGH suggests that spontaneously secreted and circulating hGH is composed of at least three hGH forms, with 22K predominating; 2) the pattern of urinary hGH is similar to that of plasma hGH after L-dopa stimulation; 3) hGH excreted in acromegaly is indistinguishable from hGH excreted by normal subjects; 4) only a minute fraction (less than 0.01%) of the hGH secreted reaches the final urine; and 5) renal interconversion among hGH forms does not appear quantitatively important.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6337176     DOI: 10.1210/jcem-56-2-305

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Application of Analyte Harvesting Nanoparticle Technology to the Measurement of Urinary HGH in Healthy Individuals.

Authors:  Alessandra Luchini; Davide Tamburro; Ruben Magni; Claudia Fredolini; Virginia Espina; Jaume Bosch; Enrico Garaci; Emanuel F Petricoin; Lance A Liotta
Journal:  J Sports Med Doping Stud       Date:  2012

Review 2.  Nanoparticle technology: amplifying the effective sensitivity of biomarker detection to create a urine test for hGH.

Authors:  Claudia Fredolini; Davide Tamburro; Guido Gambara; Benjamin S Lepene; Virginia Espina; Emanuel F Petricoin; Lance A Liotta; Alessandra Luchini
Journal:  Drug Test Anal       Date:  2009-09       Impact factor: 3.345

3.  Human growth hormone in urine: development of an ultrasensitive radiometric assay.

Authors:  T Erb; G Karolyi; A Pampalone; A N Eberle; J B Baumann; E Bürgisser; J Girard
Journal:  Experientia       Date:  1988-02-15

4.  Increase in urinary growth hormone excretion in puberty.

Authors:  D A Price; G M Addison; E D Herbert
Journal:  Arch Dis Child       Date:  1990-11       Impact factor: 3.791

5.  Urinary growth hormone excretion rates in normal and acromegalic man: a critical appraisal of its potential clinical utility.

Authors:  L M Winer; M A Shaw; G Baumann
Journal:  J Endocrinol Invest       Date:  1989 Jul-Aug       Impact factor: 4.256

6.  Evidence from the use of monoclonal antibody probes for structural heterogeneity of the growth hormone receptor.

Authors:  R Barnard; P G Bundesen; D B Rylatt; M J Waters
Journal:  Biochem J       Date:  1985-10-15       Impact factor: 3.857

7.  Stimulation of 2-deoxyglucose uptake in rat adipocytes by a human growth hormone fragment (hGH 4-15).

Authors:  F M Ng; J A Harcourt
Journal:  Diabetologia       Date:  1986-12       Impact factor: 10.122

8.  Metabolic clearance of recombinant human growth hormone in health and chronic renal failure.

Authors:  D Haffner; F Schaefer; J Girard; E Ritz; O Mehls
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

Review 9.  Growth hormone variants: a potential avenue for a better diagnostic characterization of growth hormone deficiency in children.

Authors:  A E Rigamonti; M Bozzola; G Banfi; C Meazza; E E Müller; S G Cella
Journal:  J Endocrinol Invest       Date:  2012-10-01       Impact factor: 5.467

10.  Microencapsulated octreotide pamoate in advanced gastrointestinal and pancreatic cancer: a phase I study.

Authors:  S I Helle; J Geisler; J P Poulsen; K Hestdal; K Meadows; W Collins; K M Tveit; J M Holly; P E Lønning
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.